- Home
- BDTX vs SRTS Comparison
BDTX vs SRTS Comparison
Compare BDTX & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- SRTS
- Stock Information
- Founded
- BDTX 2014
- SRTS 2010
- Country
- BDTX United States
- SRTS United States
- Employees
- BDTX N/A
- SRTS N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- SRTS Medical/Dental Instruments
- Sector
- BDTX Health Care
- SRTS Health Care
- Exchange
- BDTX Nasdaq
- SRTS Nasdaq
- Market Cap
- BDTX 96.9M
- SRTS 88.7M
- IPO Year
- BDTX 2020
- SRTS 2016
- Fundamental
- Price
- BDTX $1.61
- SRTS $4.77
- Analyst Decision
- BDTX Strong Buy
- SRTS Strong Buy
- Analyst Count
- BDTX 5
- SRTS 3
- Target Price
- BDTX $15.60
- SRTS $13.00
- AVG Volume (30 Days)
- BDTX 8.2M
- SRTS 122.0K
- Earning Date
- BDTX 03-06-2025
- SRTS 05-08-2025
- Dividend Yield
- BDTX N/A
- SRTS N/A
- EPS Growth
- BDTX N/A
- SRTS 1266.06
- EPS
- BDTX N/A
- SRTS 0.41
- Revenue
- BDTX N/A
- SRTS $41,807,000.00
- Revenue This Year
- BDTX N/A
- SRTS $9.09
- Revenue Next Year
- BDTX N/A
- SRTS $22.30
- P/E Ratio
- BDTX N/A
- SRTS $11.67
- Revenue Growth
- BDTX N/A
- SRTS 71.31
- 52 Week Low
- BDTX $1.55
- SRTS $3.09
- 52 Week High
- BDTX $7.66
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- BDTX 38.60
- SRTS 44.90
- Support Level
- BDTX $1.55
- SRTS $4.46
- Resistance Level
- BDTX $1.84
- SRTS $4.93
- Average True Range (ATR)
- BDTX 0.23
- SRTS 0.20
- MACD
- BDTX 0.01
- SRTS 0.09
- Stochastic Oscillator
- BDTX 5.26
- SRTS 69.35
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.